Waterford-based Genzyme wins FDA approval

IN a major development, Waterford -based Genzyme Corp. of the United States announced FDA approval for the production of Renagel, a further step toward consolidating the group’s Irish manufacturing presence, the company said.

Genzyme announced yesterday that the US Food and Drug Administration (FDA) had approved the production of Renagel tablets.

This clearance for the drug allows Genzyme to begin shipping Renagel a phosphate binder for patients with end-stage renal disease to markets around the world.